The outbreak of SARS-CoV-2 hit Italy by the end of February and rapidly spread from Lombardy to the rest of the country, with a number of fatalities beyond 31 000. Although all regions have reported having patients with COVID-19, the highest number of identified cases was in the provinces of eastern Lombardy.1 Several case reports and small series also suggested an association between COVID-19 and cerebrovascular events, and immune or inflammatory-mediated peripheral and central nervous system (CNS) involvement.
